MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

A pill version of blockbuster slimming drug Wegovy got the green light from US health chiefs last night, with the daily tablet expected to be launched in America in January. The approval marks the ...

The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B5.00%increase; green up pointing triangle Ozempic and Wegovy—ushering in a new era of the obesity ...

The days of the iPad being the go-to tablet choice could be nearing an end if the latest Android rival from OnePlus is anything to go by. The tech firm has just announced the OnePlus Pad Go 2, and it ...

The global smart pills market is projected to grow at a CAGR of 10–12% over the next five years, driven by the increasing prevalence of chronic diseases, rapid technological advancements in capsule ...

Results from ARTISTRY trials will be submitted to regulatory agencies for review. Topline results were announced from a phase 3 trial evaluating bictegravir 75mg/lenacapavir 50mg (BIC/LEN), an ...

Please provide your email address to receive an email when new articles are posted on . More than 90% of patients with hyperphosphatemia reached serum phosphate less than 5.5 mg/dL. Pills were seven ...

The global tablet market saw a 5.1% growth in Q3 2025, as per the latest report from Omdia. There were a total of 40 million shipments during the quarter, with Apple topping the charts, followed by ...